First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine—OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum

[1]  G. Spanakos,et al.  Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial. , 2013, Veterinary parasitology.

[2]  V. Yardley,et al.  Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis. , 2012, The Journal of antimicrobial chemotherapy.

[3]  N. F. Gontijo,et al.  Efficacy of Combined Therapy with Liposome-Encapsulated Meglumine Antimoniate and Allopurinol in Treatment of Canine Visceral Leishmaniasis , 2012, Antimicrobial Agents and Chemotherapy.

[4]  R. M. S. S. Brandão,et al.  Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil. , 2011, Veterinary parasitology.

[5]  L. Cardoso,et al.  LeishVet guidelines for the practical management of canine leishmaniosis , 2011, Parasites & Vectors.

[6]  R. Molina,et al.  Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments , 2011, Parasites & Vectors.

[7]  Armand Sánchez,et al.  Canine leishmaniasis: the key points for qPCR result interpretation , 2011, Parasites & Vectors.

[8]  L. Gradoni,et al.  Guidelines for treatment of leishmaniasis in dogs. , 2010, Journal of the American Veterinary Medical Association.

[9]  F. Vitale,et al.  Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis. , 2009, Veterinary journal.

[10]  L. Ferrer,et al.  Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. , 2009, Veterinary parasitology.

[11]  I. Cruz,et al.  Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. , 2009, Veterinary dermatology.

[12]  H. Eun,et al.  Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis , 2009, Parasitology Research.

[13]  G. Miró,et al.  Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis , 2009, Parasitology Research.

[14]  C. Couto,et al.  Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial. , 2009, Veterinary journal.

[15]  L. Campino,et al.  Diagnosis of canine leishmaniasis: conventional and molecular techniques using different tissues. , 2009, Veterinary journal.

[16]  L. Campino,et al.  Methods for diagnosis of canine leishmaniasis and immune response to infection. , 2008, Veterinary parasitology.

[17]  L. Pavone,et al.  Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. , 2008, Veterinary journal.

[18]  L. Ferrer,et al.  Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. , 2008, Trends in parasitology.

[19]  L. Cardoso,et al.  Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two. , 2008, Trends in parasitology.

[20]  I. Aroch,et al.  Canine leishmaniasis: a diagnostic and clinical challenge. , 2008, Veterinary journal.

[21]  X. Roura,et al.  Detection of Leishmania infantum DNA by fret-based real-time PCR in urine from dogs with natural clinical leishmaniosis. , 2007, Veterinary parasitology.

[22]  C. Corbett,et al.  Comparison of parasitological, immunological and molecular methods for the diagnosis of leishmaniasis in dogs with different clinical signs. , 2007, Veterinary parasitology.

[23]  J. Engel,et al.  Development of miltefosine as an oral treatment for leishmaniasis. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  Armand Sánchez,et al.  Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. , 2006, Veterinary parasitology.

[25]  M. Gramiccia,et al.  The current status of zoonotic leishmaniases and approaches to disease control. , 2005, International journal for parasitology.

[26]  C. Noli,et al.  Treatment of canine Old World visceral leishmaniasis: a systematic review. , 2005, Veterinary dermatology.

[27]  D. Britti,et al.  Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin , 2005, Veterinary Record.

[28]  T. Trotta,et al.  The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis , 2004, Parasitology Research.

[29]  Shiro Iino,et al.  [Guidelines for treatment of hepatitis C]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[30]  C. Bandi,et al.  [Quantitative PCR in the diagnosis of Leishmania]. , 2004, Parassitologia.

[31]  Jorge Alvar,et al.  Canine leishmaniasis. , 2004, Advances in parasitology.

[32]  Javier Moreno,et al.  Canine leishmaniasis: epidemiological risk and the experimental model. , 2002, Trends in parasitology.

[33]  S. Shaw,et al.  Chemotherapy of canine leishmaniosis. , 2002, Veterinary parasitology.

[34]  G. Sirera,et al.  A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  H. Murray.  Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis , 2001, Antimicrobial Agents and Chemotherapy.

[36]  J. Lamothe.  Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis. , 2001, The Journal of small animal practice.

[37]  C. Riera,et al.  Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. , 2001, Veterinary parasitology.

[38]  R. Ashford,et al.  The leishmaniases as emerging and reemerging zoonoses. , 2000, International journal for parasitology.

[39]  G. Bourdoiseau,et al.  Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). , 1999, Journal of veterinary internal medicine.

[40]  Á. Sainz,et al.  Evolution of Serum Albumin/Globulin Ratio after Antimonial Therapy in Canine Leishmaniasis , 1998, Annals of the New York Academy of Sciences.

[41]  M. Gramiccia,et al.  Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. , 1992, Annals of tropical medicine and parasitology.

[42]  G. V. van Eys,et al.  Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. , 1992, Molecular and biochemical parasitology.

[43]  R. Killick-Kendrick.  Phlebotomine vectors of the leishmaniases: a review , 1990, Medical and veterinary entomology.

[44]  F. Mancianti,et al.  Specific serodiagnosis of canine leishmaniasis by indirect immunofluorescence, indirect hemagglutination, and counterimmunoelectrophoresis. , 1988, American journal of veterinary research.